Astera Labs (ALAB) Is Down 8.7% After Russell 2500 Removal Amid Expanding AI Connectivity Focus

أستيرا لابس

Astera Labs

ALAB

0.00

  • In late June 2026, Astera Labs, Inc. was removed from both the Russell 2500 Index and the Russell 2500 Growth Benchmark, even as it remained focused on PCIe-based connectivity for AI and cloud infrastructure.
  • At the same time, the company has been expanding its AI-focused product capabilities and lab footprint, drawing attention to how index exclusion contrasts with growing operational momentum.
  • Next, we’ll examine how Astera Labs’ removal from key Russell indices, alongside rising AI connectivity demand, may reshape its investment narrative.

Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 29 best rare earth metal stocks of the very few that mine this essential strategic resource.

Astera Labs Investment Narrative Recap

To own Astera Labs today, you have to believe in sustained demand for high speed PCIe and fabric connectivity in AI and cloud data centers, and in the company’s ability to keep winning content in those systems. Its removal from the Russell 2500 indices may create some near term technical pressure but does not directly affect the core catalyst around Scorpio switches ramping into AI deployments. The key risk remains hyperscaler AI spending or architecture choices shifting away from Astera’s PCIe centric approach.

The most relevant recent development is Astera Labs’ addition to the Nasdaq 100 in June 2026, just days before its Russell deletions. That inclusion reinforces how quickly the market has come to view Astera as a large cap AI infrastructure name, even as index reshuffles send mixed technical signals. For investors focused on catalysts, the upcoming Scorpio X production ramp and ongoing lab expansions in Taiwan still sit at the center of the story.

Yet against this excitement, investors should also be aware of the risk that hyperscaler spending patterns could suddenly shift and...

Astera Labs' narrative projects $2.6 billion revenue and $668.5 million earnings by 2029.

Uncover how Astera Labs' forecasts yield a $244.97 fair value, a 38% downside to its current price.

Exploring Other Perspectives

ALAB 1-Year Stock Price Chart
ALAB 1-Year Stock Price Chart

While consensus focuses on steady AI capex and Scorpio execution, the most bullish analysts saw revenue reaching about US$3.2 billion and earnings near US$921.5 million before this index news, highlighting how sharply opinions can differ and why it is worth weighing several possible paths from here.

Explore 10 other fair value estimates on Astera Labs - why the stock might be worth less than half the current price!

Reach Your Own Conclusion

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

  • A great starting point for your Astera Labs research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
  • Our free Astera Labs research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Astera Labs' overall financial health at a glance.

No Opportunity In Astera Labs?

Early movers are already taking notice. See the stocks they're targeting before they've flown the coop:

  • This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.
  • Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
  • Uncover the next big thing with 20 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.